Quarterly report pursuant to Section 13 or 15(d)

Consolidated Condensed Balance Sheets (Parenthetical)

v3.24.1.u1
Consolidated Condensed Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Accounts Receivable, Allowance $ 252 $ 151
Stockholders' equity:    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 300,000,000 300,000,000
Common stock, shares issued (in shares) 146,821,000 145,232,000
Common stock shares outstanding (in shares) 144,434,000 142,837,000